Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuromuscular
In patients with Duchenne Muscular Dystrophy who have an exon 51 mutation, do you treat with both prednisone and Eteplirsen?
What are common side effects to look out for with Eteplirsen?
Related Questions
How do you approach patients with positive LRP4 antibodies without clinical findings of myasthenia gravis?
How do you counsel patients with dermatomyositis on sun protection?
In which clinical scenarios do you find medial and lateral plantar sensory or mixed nerve conduction studies to be valuable?
Which non-pharmacologic treatments for neuropathic pain have you found most effective?
How would one approach treating a patient with primary immunodeficiency on IVIG treatment who develops myasthenia gravis?
What treatments, after appropriate dose reductions/delays, do you offer for patients with oxaliplatin-induced cold allodynia/dysesthesia?
When would you consider testing for LGI1 antibodies in patients with unexplained neuropathic pain?
When do you obtain nerve biopsy to evaluate for vasculitic neuropathy in patients with distal symmetric polyneuropathies?
How do you use total IgG levels, if at all, to guide plasma exchange for myasthenia gravis exacerbations?
How do you decide between the gene silencing drugs for familial amyloidosis with polyneuropathy?